News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,760 Results
Type
Article (7639)
Company Profile (15)
Press Release (173106)
Multimedia
Podcasts (5)
Webinars (3)
Section
Business (49404)
Career Advice (553)
Deals (7642)
Drug Delivery (33)
Drug Development (32101)
Employer Resources (32)
FDA (5051)
Job Trends (4469)
News (95027)
Policy (8312)
Tag
Academia (546)
Accelerated approval (2)
Adcomms (6)
Allergies (27)
Alliances (12870)
ALS (26)
Alzheimer's disease (432)
Antibody-drug conjugate (ADC) (49)
Approvals (5091)
Artificial intelligence (45)
Autoimmune disease (7)
Automation (3)
Bankruptcy (57)
Best Places to Work (3306)
BIOSECURE Act (3)
Biosimilars (35)
Biotechnology (6)
Bladder cancer (30)
Brain cancer (7)
Breast cancer (85)
Cancer (777)
Cardiovascular disease (51)
Career advice (471)
Career pathing (5)
CAR-T (42)
Cell therapy (126)
Cervical cancer (8)
Clinical research (27187)
Collaboration (189)
Compensation (40)
Complete response letters (6)
COVID-19 (889)
CRISPR (9)
C-suite (32)
Cystic fibrosis (39)
Data (924)
Denatured (1)
Depression (8)
Diabetes (77)
Diagnostics (1074)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (29)
Drug pricing (8)
Drug shortages (10)
Duchenne muscular dystrophy (26)
Earnings (23614)
Editorial (8)
Employer branding (2)
Employer resources (26)
Events (23929)
Executive appointments (102)
FDA (5491)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (135)
Gene editing (27)
Generative AI (5)
Gene therapy (70)
GLP-1 (181)
Government (855)
Grass and pollen (2)
Guidances (45)
Healthcare (3954)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (36)
Indications (10)
Infectious disease (930)
Inflammatory bowel disease (44)
Inflation Reduction Act (1)
Influenza (13)
Intellectual property (26)
Interviews (83)
IPO (2897)
Job creations (1352)
Job search strategy (434)
Kidney cancer (4)
Labor market (14)
Layoffs (150)
Leadership (4)
Legal (1537)
Liver cancer (27)
Lung cancer (109)
Lymphoma (61)
Machine learning (3)
Management (12)
Manufacturing (163)
MASH (11)
Medical device (2501)
Medtech (2501)
Mergers & acquisitions (4896)
Metabolic disorders (175)
Multiple sclerosis (28)
NASH (4)
Neurodegenerative disease (18)
Neuropsychiatric disorders (1)
Neuroscience (575)
NextGen: Class of 2025 (1081)
Non-profit (566)
Now hiring (5)
Obesity (96)
Opinion (26)
Ovarian cancer (42)
Pain (35)
Pancreatic cancer (24)
Parkinson's disease (49)
Partnered (4)
Patents (38)
Patient recruitment (55)
Peanut (15)
People (9857)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase I (7825)
Phase II (11912)
Phase III (9642)
Pipeline (474)
Policy (10)
Postmarket research (1059)
Preclinical (2799)
Press Release (16)
Prostate cancer (44)
Psychedelics (6)
Radiopharmaceuticals (91)
Rare diseases (113)
Real estate (2579)
Recruiting (13)
Regulatory (6560)
Reports (11)
Research institute (582)
Resumes & cover letters (71)
Rett syndrome (3)
RNA editing (1)
RSV (13)
Schizophrenia (14)
Series A (25)
Series B (14)
Service/supplier (4)
Sickle cell disease (13)
Special edition (9)
Spinal muscular atrophy (36)
Sponsored (14)
Startups (694)
Stomach cancer (4)
Supply chain (22)
Tariffs (13)
The Weekly (4)
Vaccines (183)
Venture capitalists (5)
Weight loss (50)
Women's health (8)
Worklife (6)
Date
Today (49)
Last 7 days (221)
Last 30 days (728)
Last 365 days (8269)
2025 (2835)
2024 (8814)
2023 (9956)
2022 (12458)
2021 (13957)
2020 (13206)
2019 (9373)
2018 (6952)
2017 (7025)
2016 (6506)
2015 (7829)
2014 (5582)
2013 (4412)
2012 (4941)
2011 (5398)
2010 (5759)
Location
Africa (189)
Alabama (4)
Alaska (2)
Arizona (31)
Arkansas (3)
Asia (10582)
Australia (1957)
California (1426)
Canada (493)
China (175)
Colorado (47)
Connecticut (76)
Delaware (40)
Europe (20759)
Florida (247)
Georgia (38)
Idaho (7)
Illinois (158)
India (5)
Indiana (84)
Iowa (4)
Japan (63)
Kansas (27)
Kentucky (4)
Louisiana (1)
Maine (4)
Maryland (221)
Massachusetts (1213)
Michigan (41)
Minnesota (81)
Missouri (14)
Montana (3)
Nebraska (5)
Nevada (15)
New Hampshire (8)
New Jersey (617)
New Mexico (4)
New York (437)
North Carolina (296)
North Dakota (1)
Northern California (666)
Ohio (63)
Oklahoma (1)
Oregon (12)
Pennsylvania (365)
Puerto Rico (4)
Rhode Island (5)
South America (241)
South Carolina (7)
Southern California (511)
Tennessee (25)
Texas (205)
United States (5870)
Utah (32)
Virginia (38)
Washington D.C. (14)
Washington State (173)
West Virginia (1)
Wisconsin (8)
180,760 Results for "binding site".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
Layoffs
Lyell Cuts 73 Employees as Part of LA Site Closure
After moving the manufacturing of a CAR T drug that was part of its ImmPACT Bio acquisition to Washington, Lyell Immunopharma is closing its Los Angeles manufacturing facility, eliminating dozens of jobs there.
April 7, 2025
·
1 min read
·
Angela Gabriel
Manufacturing
Novartis Starts Construction on Two US Sites to Bolster Radioligand Therapy Manufacturing
The company is building a new facility in California, its third U.S.-based radioligand therapy production site, and expanding an Indianapolis site for producing isotopes for cancer treatment.
September 5, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Vetter’s European clinical site successfully completes first 100 aseptic fills
An increase in project orders drives further site growth
September 5, 2024
·
4 min read
Press Releases
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site
April 18, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
May 9, 2025
·
9 min read
Press Releases
Adams Clinical Site Network Announces Promotion of Dr. Stephanie Rutrick to Chief Medical Officer
April 1, 2025
·
2 min read
Press Releases
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
May 7, 2025
·
4 min read
1 of 18,076
Next
